key: cord-0985195-r6kff0ft authors: Mahy, BWJ title: A new pathogenic human parvovirus date: 2006-08-25 journal: Rev Med Virol DOI: 10.1002/rmv.511 sha: bbe1b85f2ddd462aa41a504c8c736d3b7655bc00 doc_id: 985195 cord_uid: r6kff0ft nan The first parvovirus to be detected in the human population was found in 1975 during routine screening of blood donors [1, 2] . Working in Australia, Yvonne Cossart found a parvovirus-like antigen in the sera of nine healthy blood donors and two patients. The spherical particles were 21-23 nm in diameter and a corresponding antibody was found to be widely distributed in the population. Because the original sample in which the parvovirus-like particles were seen was coded 'B19' this became the name of the human parvovirus. Following this chance discovery, a few years elapsed before a survey of serum samples archived at King's College Hospital, London revealed an association between B19 virus infection and aplastic crisis in children with sickle cell anaemia [3] . Later in 1981 it was reported that 24 of 28 young children in Jamaica with sickle cell anaemia who had an aplastic crisis were infected with a parvovirus [4] and similar findings were reported concerning adult patients with sickle cell anaemia in Chicago where aplastic crisis was associated with acute infection with a human parvovirus [5] . In 1983, the virus was shown to be the cause of a childhood rash called erythema infectiosum (fifth disease) [6] , and this was confirmed 2 years later by experimentally infecting human volunteers with the virus [7] . The final step in characterising the virus, which appears to infect and damage early erythroid progenitor cells, was to characterise, clone and sequence the genome of the virus, and this established definitively that it was a parvovirus [8, 9] . However when the sequence was analysed in detail, it was phylogenetically distinct from the existing genera (Parvovirus and Dependovirus), and so was placed in a new genus named Erythrovirus. In 2001, Allander et al. working at the NIH reported a new method for virus 'discovery' in serum or plasma based on treatment of the sample with DNase followed by restriction enzyme digestion and sequence-independent single primer amplification of the fragments [10] . Whilst evaluating the method, they detected two previously unknown bovine parvoviruses in the bovine serum used as diluent. When sequenced, the two viruses were distinct, but different from all other known parvoviruses except a virus of dogs, Canine minute virus. So it was decided by the ICTV to include the bovine and canine viruses in a new genus to be named Bocavirus, of the subfamily Parvovirinae within the family Parvoviridae [11] . When Allander et al. now working in Sweden, applied the virus discovery method to screening of pooled human respiratory tract samples, they found a novel human coronavirus (which is related by sequence to the newly described human coronavirus HKU1 [12] ), and a novel human parvovirus, which is related by sequence to the genus Bocavirus, and so has been provisionally named human bocavirus [13] . Several laboratories worldwide have now confirmed the existence of human bocavirus in 1. .7% of respiratory samples tested, and it appears to be associated with lower respiratory tract disease, though in many cases there is co-infection with another respiratory virus, so the exact role of human bocavirus in pathogenesis remains the subject of further studies. So far, reports have been published from Australia [14] , Canada [15] , France [16] , Japan [17] and Korea [18] . More are in press. In the past, the majority of viruses infecting humans were found because of the disease symptoms they caused. It is, therefore, worth noting that both human parvoviruses, B19 virus and human bocavirus, were initially discovered without an obvious association with disease. This suggests that a systematic search of human samples for viruses of other families might be profitable, as suggested by Allander et al. [13] . For example, could there be a human arterivirus waiting to be discovered? E E D D I I T T O O R R I I A A L L Parvovirus-like particles in human sera A new particulate antigen present in serum Parvovirus infections and hypoplastic crisis in sickle-cell anaemia Outbreak of aplastic crises in sickle cell anaemia associated with parvovirus-like agent Infection with parvovirus-like virus and aplastic crisis in chronic hemolytic anemia Human parvovirus, the cause of erythema infectiosum (fifth disease)? Experimental parvoviral infection in humans Characterization of the genome of the agent of erythrocyte aplasia permits its classification as a human parvovirus Characterization and molecular cloning of a human parvovirus genome A virus discovery method incorporating DNase treatment and its application to the identification of two bovine parvovirus species Virus Taxonomy. Eighth Report of the International Committee on Taxonomy of Viruses Characterization and complete genome sequence of a novel coronavirus HKU1, from patients with pneumonia Cloning of a human parvovirus by molecular screening of respiratory tract samples Evidence of human coronavirus HKU1 and human bocavirus in Australian children Human bocavirus infection Human bocavirus in children Detection of human bocavirus in Japanese children with lower. respiratory tract infections Evidence of Human Bocavirus infection in hospitalized children with acute lower respiratory tract infection in Korea